Juvenescence: Investing in the Age of Longevity

3.85 avg rating
( 20 ratings by Goodreads )
)  
9780993047817: Juvenescence: Investing in the Age of Longevity
View all copies of this ISBN edition:
 
 

This new book by Jim Mellon and Al Chalabi is a layman's guide to longevity. It investigates the new technologies and explains how to benefit from the life extending technologies both personally and professionally. It helps readers unravel the science, offers ideas on potential investment and reveals the views of the key opinion leaders.

"synopsis" may belong to another edition of this title.

Review:

"Jim Mellon s vision may be optimistic but it s certainly not fanciful. He came to the conclusions he draws in his new book, Juvenescence, after he immersed himself in the subject of longevity research for well over a year. This included a 7,000-mile road trip around America, visiting scientists at the cutting edge of this research...Mellon s book offers three possible portfolios and includes a thorough analysis of the companies recommended." ----Julie Blackburn, The Telegraph

About the Author:

Jim Mellon is an investor with an interest in several industries. After studying PPE at Oxford, Jim worked in Asia and in the US for two fund management companies, GT Management and Thornton & Co, before establishing his own business in 1991. This business is now known by two names - Charlemagne Capital, recently acquired, and Regent Pacific Group, listed in Hong Kong. Jim's private investment company, The Burnbrae Group, is a substantial landlord in Germany and the Isle of Man, and owns the group Sleepwell Hotels. Jim is chairman and major shareholder of Manx Financial Group, Port Erin Biopharma Invesments and SalvaRx Group. He is also a director of Condor Gold, Fast Forward Innovations, Portage Biotech and West African Minerals Corporation, all publicly listed companies. A new venture, Juvenescence will provide investors with the opportunity to invest alongside his partners in longevity, is expected to be launched sometime in 2017.Amongst his many successes, Jim is well know for notching up one of the AIM market's biggest successes with the sale of Uramin to Areva, the French nuclear giant.Al Chalabi is an entrepreneur and business advisor with a diverse professional background. He grew up in the UK and studied Aeronautical Engineering at the University of Southampton. Al started his career in Canada, working as an engineer in process automation systems. After his MBA, he worked as a management consultant, specialising in technology, strategy and operations, based out of Hong Kong. Since 2008, Al has been running CASP-R, a firm he founded to provide independent research and advisory services to investors and corporations, with a focus on real estate and technology. He is active in various Hong Kong-based angel investor groups that provide seed and growth funding to Asian-based tech and healthcare companies.

"About this title" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

Mellon Jim
ISBN 10: 0993047815 ISBN 13: 9780993047817
New Paperback Quantity Available: 1
Seller:
Revaluation Books
(Exeter, United Kingdom)

Book Description 2017. Paperback. Condition: Brand New. 250 pages. 8.25x6.00x1.25 inches. In Stock. Seller Inventory # zk0993047815

More information about this seller | Contact this seller

Buy New
26.33
Convert currency

Add to Basket

Shipping: 35
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

Mellon Jim, Chalabi Al
Published by Fruitful Publications (2017)
ISBN 10: 0993047815 ISBN 13: 9780993047817
New Paperback Quantity Available: 2
Seller:
Save With Sam
(North Miami, FL, U.S.A.)

Book Description Fruitful Publications, 2017. Paperback. Condition: New. Brand New!. Seller Inventory # VIB0993047815

More information about this seller | Contact this seller

Buy New
82.26
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds